![Robert Arch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Arch
President bij
Immunophotonics, Inc.
Profiel
Robert H.
Arch currently works at Immunophotonics, Inc., as President from 2025.
Dr. Arch also formerly worked at OncoSec Medical, Inc., as President, CEO & Non-Independent Director from 2022 to 2023, Elpiscience Biopharma Ltd., as Head-Research from 2019 to 2021, and China Novartis Institutes for BioMedical Research Co., Ltd., as Head-Liver Disease Department from 2017 to 2019.
Dr. Arch received his doctorate degree from Julius-Maximilians-Universität Würzburg.
Actieve functies van Robert Arch
| Bedrijven | Functie | Begin |
|---|---|---|
Immunophotonics, Inc.
 Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine | President | 22-09-2025 |
Eerdere bekende functies van Robert Arch
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Algemeen Directeur | 14-06-2023 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Hoofd Techniek/Wetenschap/O&O | 01-06-2021 |
China Novartis Institutes for BioMedical Research Co., Ltd. | Corporate Officer/Principal | 01-10-2019 |
Opleiding van Robert Arch
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
23
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Immunophotonics, Inc.
Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine | Health Technology |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Health Technology |
China Novartis Institutes for BioMedical Research Co., Ltd. |
